Article
[The genome and the consumer].
Ugeskrift for laeger - 10 Nov 2014
Christiansen Gunna
Abstract excerpt
Consumergenetics has developed so fast that it became possible for consumers to obtain genome risk information based on single nucleotide polymorphisms data of over 250 diseases/conditions for just 99 USD. In November 2013, the American Food and Drug Administration (FDA) ordered the company 23andMe to stop returning health results because they found a lack of scientific evidence of the reposted disease risks. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
